Histological and Immunohistochemical Identification of Atypical Ductal Mammary Hyperplasia as a Preneoplastic Marker in Dogs

Veterinary Pathology

Volumn 49, Issue 2, 2012, Pages 322-329

  Ferreira, E ^a   Gobbi, H ^a   Saraiva, B S ^a   Cassali, G D ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

atypical hyperplasia; female dog; immunohistochemistry; mammary; neoplasm

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; TUMOR MARKER;

ANIMAL; ANIMAL DISEASE; ARTICLE; CELL TRANSFORMATION; DOG; DOG DISEASE; EXPERIMENTAL MAMMARY NEOPLASM; FEMALE; GENE EXPRESSION REGULATION; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PRECANCER; UDDER;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DOG DISEASES; DOGS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; PRECANCEROUS CONDITIONS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, PROGESTERONE; TUMOR MARKERS, BIOLOGICAL;

CANIS FAMILIARIS;

EID: 84857668032     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1177/0300985810396105     Document Type: Article

References (47)

1. Abdel-fatah TM,Powe DG,Hodi Z,Lee AH,Reis-Filho JS,Ellis IO:.High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma.Am J Surg Pathol. 2007;31 (3): 417-426.
2. Antuofermo E,Miller MA,Pirino S,Xie J,Badve S,Mohammed SI:.Spontaneous mammary intraepithelial lesions in dogs-a model of breast cancer.Cancer Epidemiol Biomarkers Prev. 2007;16 (11): 2247-2256.
3. Benjamim SA,Lee AC,Saunders WJ:.Classification and behavior of canine mammary epithelial neoplasms based on life-span observations in beagles.Vet Pathol. 1999;36:423-436.
4. Bratthauer GL,Moinfar F,Stamatakos MD,Mezzetti TP,Shekitka KM,Man YG,Tavassoli FA:.Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias.Hum Pathol. 2002;33 (6): 620-627.
5. Cameron AM,Faulkin LJ.Hyperplastic and inflammatory nodules in the canine mammary gland.J Nat Cancer Inst. 1971;47:1277-1287.
6. Clarke RB,Howell A,Potten CS,Anderson E:.Dissociation between steroid receptor expression and cell proliferation in the human breast.Cancer Res. 1997;57:4987-4991.
7. Cohen SM,Ellwein LB:.Cell proliferation in carcinogenesis.Science. 1990;249:1007-1011.
8. Concannon P,Altszuler N,Hampshire J,Butler WR,Hansel W:.Growth hormone, prolactin, and cortisol in dogs developing mammary nodules and an acromegaly-like appearance during treatment with medroxyprogesterone acetate.Endocrinology. 1980;106:1173-1177.
9. Donnay I,Devleeschouwer N,Wouters-Ballman P,Leclercq G,Verstegen J:.Relationship between receptors for epidermal growth factor and steroid hormones in normal, dysplastic and neoplastic canine mammary tissues.Res Vet Sci. 1996;60 (3): 251-254.
10. Faustino AM,van Garderen E,Schalken JA,Nederbragt H:.Tenascin expression in normal, hyperplastic, dysplastic and neoplastic canine mammary tissues.J Comp Path. 2002;126:1-8.
11. Ferreira E,Bertagnolli AC,Cavalcanti MF,Schmitt FC,Cassali GD:.The relationship between tumour size and expression of prognostic markers in benign and malignant canine mammary tumour.Vet Comp Oncol. 2009;7:230-235.
12. Fitzgibbons PL,Henson DE,Hutter RV:.Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement.Arch Pathol Lab Med. 1998;122:1053-1055.
13. Gama A,Alves A,Gartner F,Schmitt F:.p63: a novel myoepithelial cell marker in canine mammary tissues.Vet Pathol. 2003;40:412-420.
14. Gama A,Alves A,Schmitt F:.Identification of molecular phenotypes in canine mammary carcinomas with clinical implications: application of the human classification.Virchows Arch. 2008;453:123-132.
15. Gobbi H,Dupont WD,Simpson JF,Plummer WD,Schuyler PA,Olson SJ,Arteaga CL,Page DL:.Transforming growth factor-beta and breast cancer risk in women with mammary epithelial hyperplasia.J Natl Cancer Inst. 1999;91:2096-2101.
16. Götte M,Kersting C,Radke I,Kiesel L,Wülfing P:.An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ.Breast Cancer Res. 2007;9 (1): R8.
17. Harvey JM,Clark GM,Osborne CK,Allred DC:.Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.J Clin Oncol. 1999;17 (5): 1474-1481.
18. Helguero LA,Lindberg K,Gardmo C,Schwend T,Gustafsson JA,Haldosén LA:.Different roles of estrogen receptors alpha and beta in the regulation of E-cadherin protein levels in a mouse mammary epithelial cell line.Cancer Res. 2008;68 (21): 8695-8704.
19. Ishikawa T,Inoue S,Kakinuma C,Kuwayama C,Hamada Y,Shibutani Y:.Growth-stimulating effect of dienogest, a synthetic steroid, on rodent, canine, and primate mammary glands.Toxicology. 2000;151:91-101.
20. Karayannopoulou M,Kaldrymidou E,Constantinidis TC,Dessiris A:.Histological grading and prognosis in dogs with mammary carcinomas: application of a human grading method.J Comp Pathol. 2005;20:1-7.
21. Lacroix-Triki M,Mery E,Voigt JJ,Istier L,Rochaix P:.Value of cytokeratin 5/6 immunostaining using D5/16 B4 antibody in the spectrum of proliferative intraepithelial lesions of the breast: a comparative study with 34betaE12 antibody.Virchows Arch. 2003;442 (6): 548-554.
22. Lakhani RS:.The transformation from hyperplasia to invasive carcinoma of the breast.J Pathol. 1999;187:272-278.
23. Martin de las Mulas J,Ordás J,Millán Y,Fernández-Soria V,Ramón y Cajal S:.Oncogene HER-2 in canine mammary gland carcinomas: an immunohistochemical and chromogenic in situ hybridization study.Breast Cancer Res Treat. 2003;80:363-367.
24. Mareel M,Leroy A:.Clinical, cellular, and molecular aspects of cancer invasion.Physiol Rev. 2003;83:337-376.
25. Marinelli L,Gabai G,Wolfswinkel J,Mol JA:.Mammary steroid metabolizing enzymes in relation to hyperplasia and tumorigenesis in the dog.J Steroid Biochem Molec Biol. 2004;92:167-173.
26. Misdorp W,Else RW,Hellmén E,Lipscomb TP:.Histological Classification of Mammary Tumors of the Dog and the Cat. 1999;vol VII:1-59.
27. Mouser P,Miller MA,Antuofermo E,Badve SS,Mohammed SI:.Prevalence and classification of spontaneous mammary intraepithelial lesions in dogs without clinical mammary disease.Vet Pathol. 2010;47 (2): 275-284.
28. Otterbach F,Bànkfalvi A,Bergner S,Decker T,Krech R,Boecker W:.Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast.Histopathology. 2000;37 (3): 232-240.
29. Page DL,Dupont DW,Rogers LW,Rados MS:.Atypical hyperplastic lesions of the female breast: a long-term follow-up study.Cancer. 1985;55:2698-2708.
30. Page DL:.The woman at high risk for breast cancer: importance of hyperplasia.Surg Clin North Am. 1996;76:221-230.
31. Page DL,Jensen RA,Simpson JF,Dupont WD:.Historical and epidemiologic background of human premalignant breast disease.J Mammary Gland Biol Neoplasia. 2000;5 (4): 341-349.
32. Peleteiro MC:.Tumores mamários na cadela e na gata.Ver Port Ciência Vet. 1994;89:10-34.
33. Rao A,Parker S,Ratzer E,Stephens J,Fenoglio MMD:.Atypical ductal hyperplasia of the breast diagnosed by 11-gauge directional vacuum-assisted biopsy.Am J Surg. 2002;184:534-537.
34. Rosen PP,Oberman HA:.Tumors of the Mammary Gland. 1993;7:390.
35. Schneider R:.Comparison of age, sex and incidence rates in human and canine breast cancer.Cancer. 1970;26:419-426.
36. Schnitt SJ,Connolly JL,Tavassoli FA,Fechner RE,Kempson RL,Gelman R,Page DL:.Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria.Am J Surg Pathol. 199;16:1133-1143.
37. Sfacteria A,Bertani C,Costantino G,Del Bue M,Paiardini M,Cervasi B,Piedimonte A,De Vico G:.Cyclin D1 expression in pre-cancerous and cancerous lesions of the canine mammary gland.J Comp Path. 2003;128:245-251.
38. Shaaban AM,Sloane JP,West CR,Foster CS:.Breast cancer risk in usual ductal hyperplasia is defined by estrogen receptor-alpha and Ki-67 expression.Am J Pathol. 2002;160 (2): 597-604.
39. Shaw JA,Udokang K,Mosquera JM,Chauhan H,Jones JL,Walker RA:.Oestrogen receptors alpha and beta in normal human breast and breast carcinomas.Pathology. 2002;198:450-457.
40. Shirley SH,Rundhaug JE,Tian J,Cullinan-Ammann N,Lambertz I,Conti CJ,Fuchs-Young R:.Transcriptional regulation of estrogen receptor-alpha by p53 in human breast cancer cells.Cancer Res. 2009;69 (8): 3405-3414.
41. Tavassoli FA,Schnitt S,Hoefler H,Boecker W,Rosai J,Heywang-Köbrunner H,Monfair RF,Ellis IO,Lakhani SR:.Intraductal proliferative lesions.In: World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of Breast Female Genital Organs. 2003;:63-75.
42. Tavassoli FA,Norris HJ:.A comparison of the results of longterm follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast.Cancer. 1990;65:518-529.
43. Torres LN,Matera JM,Vasconcellos CH,Avanzo JL,Hernandez-Blazquez FJ,Dagli MLZ:.Expression of connexins 26 and 43 in canine hyperplastic and neoplastic mammary glands.Vet Pathol. 2005;42:633-641.
44. Turashvili G,Bouchal J,Ehrmann J,Fridman E,Skarda J,Kolar Z:.Novel immunohistochemical markers for the differentiation of lobular and ductal invasive breast carcinomas.Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2007;151 (1): 59-64.
45. Veronesi MC,Battocchio M,Rizzi C,Sironi G:.Relationship between dysplastic and neoplastic mammary lesions and pseudopregnancy in the bitch.Vet Res Commun. 2003;27 (Suppl 1): 245-247.
46. Wolff AC,Hammond ME,Schwartz JN,Hagerty KL,Allred DC,Cote RJ,Dowsett M,Fitzgibbons PL,Hanna WM,Langer A,McShane LM,Paik S,Pegram MD,Perez EA,Press MF,Rhodes A,Sturgeon C,Taube SE,Tubbs R,Vance GH,van de Vijver M,Wheeler TM,Hayes DF:.American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.Arch Pathol Lab Med. 2007;25 (1): 118-145.
47. Ye Y,Xiao Y,Wang W,Yearsley K,Gao JX,Shetuni B,Barsky SH:.ERalpha signaling through slug regulates E-cadherin and EMT.Oncogene. 2010;29 (10): 1451-1462.